MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
81 hedge funds and large institutions have $61.4M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less capital invested
Capital invested by funds: $74M → $61.4M (-$12.7M)
Holders
81
Holding in Top 10
–
Calls
$436K
Puts
$192K
Top Buyers
| 1 | +$1.87M | |
| 2 | +$1.36M | |
| 3 | +$957K | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$531K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$440K |
Top Sellers
| 1 | -$1.78M | |
| 2 | -$681K | |
| 3 | -$588K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$447K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$166K |